In its recent feature on Northern Ireland’s life sciences sector, Reuters highlighted something we see every day: this region is quietly building world-class healthcare technology with global impact.

From new eye treatments and cancer detection to advanced 3D surgical planning, the piece showcases why the UK continues to be a destination for medical innovation. We’re proud that Axial3D was part of that story.

As our founder and Chief Strategy Officer, Dan Crawford, shared in the interview, “Axial3D is a specialist software company. We take traditional 2D medical images and transform them into patient-specific 3D files using machine learning. That shift from flat imaging to intelligent, scalable 3D data is what enables modern, personalized medicine.“

But the story isn’t just about technology, it’s about scale.

Belfast has been a phenomenal place to grow a company like Axial3D. The city has deep engineering roots, from shipbuilding and linen to medical technology pioneers like Frank Pantridge, inventor of the portable defibrillator. That legacy of practical innovation continues today in the strength of local medical engineering talent.

Support from organizations like the UK Department for Business and Trade and Innovate UK has also played a major role in helping companies move from seed to startup to global scale. Through trade missions and export initiatives, Axial3D has expanded its reach into major U.S. markets, where orthopedics and cardiology innovation are thriving.

The UK’s connectivity to both the EU and the U.S., combined with strong funding infrastructure and public-private collaboration, creates a unique launchpad for medical technology companies ready to grow globally.

Ultimately, though, as Dan said, “The number one ingredient in building a company is talent. And Belfast has some of the best on the planet.“

The Reuters piece captures this momentum perfectly. Innovation is happening here, and it’s scaling worldwide.